In a physician-led program, this often includes: Review of medical history and medications Assessment for contraindications Baseline labs to evaluate metabolic health Blood pressure, heart rate, and body composition tracking This ensures the medication is appropriate, safe, and tailored to youreducing risk and improving outcomes
Other outcomes were pharmacodynamic parameters including the international normalized ratio (INR) of the prothrombin time (warfarin studies), lipid levels (statin studies) and gonadotropins or progesterone levels (combined oral contraceptive [COC] studies)
The image below highlights the mechanisms of both GLP-1 and GIP, along with a callout to the newest treatment optiona triple incretin that also includes glucagonexpected to be approved in late 2025 to early 2026
Tailored support and realistic expectations are key
Protocol summary table Diet and lifestyle optimization for thyroid patients on tirzepatide Managing the dual demands of thyroid health and GLP-1 treatment requires thoughtful attention to nutrition, hydration, and daily habits
